EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Prevalence of cardiometabolic diseases among ART ‐naïve people with HIV : A global systematic review and meta‐analysis

Peter Vanes Ebasone iD, Anastase Dzudie, Nasheeta Peer, Jerry Aseneh, Romain Ebene Mbende, Andre Pascal Kengne

HIV Medicine · 2026

DOI: 10.1111/hiv.70254 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift HIV Medicine, 2026. Verfasst von Peter Vanes Ebasone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Dyslipidemias, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The burden of cardiometabolic diseases (CMDs) is rising in people with HIV (PWH). While extensive data exist on CMD prevalence in PWH receiving antiretroviral therapy (ART), comprehensive data on ART‐naïve PWH are scarce. We aimed to estimate the global prevalence of hypertension, diabetes, obesity and dyslipidaemia among ART‐naïve PWH and compare estimates with those on ART and HIV‐negative populations.

Methods

This systematic review and meta‐analysis included a search of PubMed‐MEDLINE, CINAHL, SCOPUS, Academic Search Premier, Africa‐Wide Information and Africa‐Journals Online for original articles published up to June 2024. Cross‐sectional, cohort and case‐control studies providing baseline data on CMD prevalence were included. Studies had to include ART‐naïve PWH aged ≥15 years. Two independent reviewers conducted studies screening, data extraction and methodological quality assessment. A random‐effects meta‐analysis with double arc‐sine transformation was used for prevalence estimates. The study was registered with PROSPERO (CRD42021226001).

Results

We included 184 studies published between 2000 and 2024, involving a total of 424 629 participants. The global pooled prevalence among ART‐naïve PWH was 14.2% (95% CI: 12.4–16.1) for hypertension, 3.6% (2.9–4.3) for diabetes, 11.5% (10.3–12.9) for body mass index‐based obesity, 18.3% (12.7–24.6) for waist circumference‐based obesity, 14.8% (12.1–17.8) for elevated total cholesterol, 17.6% (11.3–24.8) for elevated low‐density lipoprotein cholesterol, 22.9% (19.3–26.7) for elevated triglycerides and 54.6% (48.2–61.0) for low high‐density lipoprotein cholesterol, all with high heterogeneity. Significant regional variations in the prevalence of diabetes, obesity and dyslipidaemia were observed according to UNAIDS regions.

Discussion

We found a notable prevalence of CMDs in ART‐naïve PWH, with significant regional variations in the prevalence of diabetes, obesity and dyslipidaemia. This highlights the need for targeted interventions and early screening to address the growing CMD burden among PWH.

Conclusion

ART‐naïve PWH face a considerable CMD burden, emphasizing the importance of early detection and management. Regional differences in CMD prevalence call for tailored public health strategies and integration of CMD prevention into HIV care protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes MellitusDyslipidemiasHIV InfectionsHypertensionObesityHumansGlobal HealthPrevalence

Stichwörter der Autor:innen

HIVantiretroviral therapycardiometabolic risk factorsmeta‐analysisprevalencesystematic review

Autor:innen und Institutionen

  • Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Clinical Research Education Networking and Consultancy (CRENC), Yaounde, Cameroon.
  • Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
  • Lown Scholars Program, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
  • African Population and Health Research Center, Nairobi, Kenya.

ORCID-Profile: Peter Vanes Ebasone

Förderung

  • European and Developing Countries Clinical Trials Partnership

Zitieren

APA

Ebasone, P. V., Dzudie, A., Peer, N., Aseneh, J., Mbende, R. E., & Kengne, A. P. (2026). Prevalence of cardiometabolic diseases among ART ‐naïve people with HIV : A global systematic review and meta‐analysis. HIV Medicine. https://doi.org/10.1111/hiv.70254

Vancouver

Ebasone PV, Dzudie A, Peer N, Aseneh J, Mbende RE, Kengne AP. Prevalence of cardiometabolic diseases among ART ‐naïve people with HIV : A global systematic review and meta‐analysis. HIV Medicine. 2026. doi:10.1111/hiv.70254

BibTeX
@article{Ebasone2026,
  author = {Ebasone, Peter Vanes and Dzudie, Anastase and Peer, Nasheeta and Aseneh, Jerry and Mbende, Romain Ebene and Kengne, Andre Pascal},
  title = {Prevalence of cardiometabolic diseases among ART ‐naïve people with HIV : A global systematic review and meta‐analysis},
  journal = {HIV Medicine},
  year = {2026},
  doi = {10.1111/hiv.70254}
}
Kostenlos starten →